imiquimod has been researched along with Histiocytosis, Langerhans-Cell in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Barbarot, S; Fraitag, S; Legroux, J; Mesnard, C; Petrot, D; Thomas, C | 1 |
| Carson, J; Jenkinson, H; O'Kane, D | 1 |
| Demierre, MF; Stefanato, CM; Taverna, JA; Wax, FD | 1 |
1 review(s) available for imiquimod and Histiocytosis, Langerhans-Cell
| Article | Year |
|---|---|
Langerhans cell histiocytosis associated with breast carcinoma successfully treated with topical imiquimod.
Topics: Adjuvants, Immunologic; Aminoquinolines; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Histiocytosis, Langerhans-Cell; Humans; Imiquimod; Middle Aged; Treatment Outcome | 2009 |
2 other study(ies) available for imiquimod and Histiocytosis, Langerhans-Cell
| Article | Year |
|---|---|
Uncommon preputial localization of Langerhans cell histiocytosis.
Topics: Adolescent; Histiocytosis, Langerhans-Cell; Humans; Imiquimod; Male; Mometasone Furoate; Remission, Spontaneous; Skin Neoplasms | 2021 |
Adult cutaneous Langerhans cell histiocytosis responsive to topical imiquimod.
Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Female; Histiocytosis, Langerhans-Cell; Humans; Imiquimod; Treatment Outcome | 2006 |